Acute myeloid leukemia pathophysiology: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 15: Line 15:
The clinical signs and symptoms of AML result from the fact that, as the leukemic clone of cells grows, it tends to displace or interfere with the development of normal blood cells in the bone marrow.<ref>
The clinical signs and symptoms of AML result from the fact that, as the leukemic clone of cells grows, it tends to displace or interfere with the development of normal blood cells in the bone marrow.<ref>
Abeloff, Martin et al. (2004), p. 2828.</ref> This leads to [[neutropenia]], [[anemia]], and [[thrombocytopenia]]. The symptoms of AML are in turn often due to the low numbers of these normal blood elements. In rare cases, patients can develop a ''[[chloroma]]'', or solid tumor of leukemic cells outside the bone marrow, which can cause various symptoms depending on its location.
Abeloff, Martin et al. (2004), p. 2828.</ref> This leads to [[neutropenia]], [[anemia]], and [[thrombocytopenia]]. The symptoms of AML are in turn often due to the low numbers of these normal blood elements. In rare cases, patients can develop a ''[[chloroma]]'', or solid tumor of leukemic cells outside the bone marrow, which can cause various symptoms depending on its location.
===Microscopic Pathology===
(Images shown below are courtesy of Melih Aktan MD., Istanbul Medical Faculty - Turkey, and Kyoto University - Japan)
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M0 0001.jpg|AML-M0
Image:AML-M1 0002.jpg|AML-M1
</gallery>
</div>
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M1 peroxidase 0001.jpg|AML-M1 peroxidase
Image:AML-M1 0005.jpg|AML-M1
</gallery>
</div>
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M1 0004.jpg|AML-M1
Image:AML-M1 0003.jpg|AML-M1
</gallery>
</div>
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M2 0002.jpg|AML-M2
Image:AML-M2 0001.jpg|AML-M2
</gallery>
</div>
</div>
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M2 0004.jpg|AML-M2
Image:AML-M2 0003.jpg|AML-M2
</gallery>
</div>
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M3 0006.jpg|AML-M3 
Image:AML-M3 0004.jpg|AML-M3
</gallery>
</div>
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M3 0002.jpg|AML-M3
Image:AML-M3 0001.jpg|AML-M3
</gallery>
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M3 Auer bodies 0005.jpg|AML-M3 Auer bodies
Image:AML-M3 Auer bodies 0003.jpg|AML-M3 Auer bodies
</gallery>
</div>
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M3 variation 0007.jpg|AML-M3 variation
Image:AML-M4 0001.jpg|AML-M4
</gallery>
</div>
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M5a 0003.jpg|AML-M5a
Image:AML-M5a 0001.jpg|AML-M5a
</gallery>
</div>
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M5a alpha naphtyle acetat 0002.jpg|AML-M5a (alpha naphtyle acetat)
Image:AML-M5b 0001.jpg|AML-M5b
</gallery>
</div>
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M5b 0002.jpg|AML-M5b
Image:AML-M7 0001.jpg|AML-M7
Image:AML-M7 CD41 0001.jpg|AML-M7
</gallery>
</div>


==References==
==References==

Revision as of 13:29, 8 August 2012

Acute myeloid leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute myeloid leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardigram

Chest X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute myeloid leukemia pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute myeloid leukemia pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute myeloid leukemia pathophysiology

CDC on Acute myeloid leukemia pathophysiology

Acute myeloid leukemia pathophysiology in the news

Blogs on Acute myeloid leukemia pathophysiology

Directions to Hospitals Treating Acute myeloid leukemia

Risk calculators and risk factors for Acute myeloid leukemia pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Overview

Pathophysiology

The malignant cell in AML is the myeloblast. In normal hematopoiesis, the myeloblast is an immature precursor of myeloid white blood cells; a normal myeloblast will gradually mature into a mature white blood cell. However, in AML, a single myeloblast accumulates genetic changes which "freeze" the cell in its immature state and prevent differentiation.[1] Such a mutation alone does not cause leukemia; however, when such a "differentiation arrest" is combined with other mutations which disrupt genes controlling proliferation, the result is the uncontrolled growth of an immature clone of cells, leading to the clinical entity of AML.[2]

Much of the diversity and heterogeneity of AML stems from the fact that leukemic transformation can occur at a number of different steps along the differentiation pathway.[3] Modern classification schemes for AML recognize that the characteristics and behavior of the leukemic cell (and the leukemia) may depend on the stage at which differentiation was halted.

Specific cytogenetic abnormalities can be found in many patients with AML; the types of chromosomal abnormalities often have prognostic significance.[4] The chromosomal translocations encode abnormal fusion proteins, usually transcription factors whose altered properties may cause the "differentiation arrest."[5] For example, in acute promyelocytic leukemia, the t(15;17) translocation produces a PML-RARα fusion protein which binds to the retinoic acid receptor element in the promoters of several myeloid-specific genes and inhibits myeloid differentiation.[6]

The clinical signs and symptoms of AML result from the fact that, as the leukemic clone of cells grows, it tends to displace or interfere with the development of normal blood cells in the bone marrow.[7] This leads to neutropenia, anemia, and thrombocytopenia. The symptoms of AML are in turn often due to the low numbers of these normal blood elements. In rare cases, patients can develop a chloroma, or solid tumor of leukemic cells outside the bone marrow, which can cause various symptoms depending on its location.

Microscopic Pathology

(Images shown below are courtesy of Melih Aktan MD., Istanbul Medical Faculty - Turkey, and Kyoto University - Japan)

  • AML-M0

    AML-M0

  • AML-M1

    AML-M1


  • AML-M1 peroxidase

    AML-M1 peroxidase

  • AML-M1

    AML-M1


  • AML-M1

    AML-M1

  • AML-M1

    AML-M1


  • AML-M2

    AML-M2

  • AML-M2

    AML-M2


  • AML-M2

    AML-M2

  • AML-M2

    AML-M2


  • AML-M3

    AML-M3

  • AML-M3

    AML-M3


  • AML-M3

    AML-M3

  • AML-M3

    AML-M3


  • AML-M3 Auer bodies

    AML-M3 Auer bodies

  • AML-M3 Auer bodies

    AML-M3 Auer bodies


  • AML-M3 variation

    AML-M3 variation

  • AML-M4

    AML-M4


  • AML-M5a

    AML-M5a

  • AML-M5a

    AML-M5a


  • AML-M5a (alpha naphtyle acetat)

    AML-M5a (alpha naphtyle acetat)

  • AML-M5b

    AML-M5b


  • AML-M5b

    AML-M5b

  • AML-M7

    AML-M7

  • AML-M7

    AML-M7

References

  1. ↑ Fialkow PJ: Clonal origin of human tumors. Biochim Biophys Acta 1976;458:283–321. PMID 1067873
  2. ↑ Fialkow PJ, Janssen JW, Bartram CR: Clonal remissions in acute nonlymphocytic leukemia: Evidence for a multistep pathogenesis of the malignancy. Blood 1991;77:1415–1517. PMID 2009365
  3. ↑ Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730–737. PMID 9212098
  4. ↑ Abeloff, Martin et al. (2004), pp. 2831–32.
  5. ↑ Greer, John P., et al. Wintrobe's Clinical Hematology, 11th ed. Philadelphia: Lippincott, Williams, and Wilkins, 2004. p. 2045–2062
  6. ↑ Melnick A, Licht JD. Deconstructing a disease: RARα its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999;93:3167–3215. PMID 10233871
  7. ↑ Abeloff, Martin et al. (2004), p. 2828.

Template:Hematology



Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Acute_myeloid_leukemia_pathophysiology&oldid=666784"